TrialSeminars in hematology2021

A pilot clinical trial of oral tetrahydrouridine/decitabine for noncytotoxic epigenetic therapy of chemoresistant lymphoid malignancies.

Brian Hill et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.